ABSTRACT
INTRODUCTION
The absolute incidence of stroke will continue to rise globally with a predicted 12 million stroke deaths in (end of treatment and follow-up) of the studies and allocating them to either being an RGS condition, OT 126 condition in which patients followed standard protocols and follow-up (i.e. no-therapy). We then calculated 127 the improvement rate per week-normalized within-subjects according to their respective recovery potential 128 (i.e., the improvement observed normalized to the total amount that each can gain concerning their baseline) 129 in standardized clinical scales. The normalized improvement on scale i at time t, was defined as: (Rodriguez et al., 2011; Duff et al., 2013 ) 3 RGS Acute 12w;3d/w;20min; 10 63.5(29) 11(17) 40 30 2/2/2/3/1 (da Silva Duff et al., 2013) 4 Control Acute 3w;5d/w;20min; 5 64(16) 13(5) 60 60 2/2/0/0/1 (Rodriguez et al., 2011; Duff et al., 2013) Cameirão et al., 2012) Intervention: duration of included protocols indicated per number of weeks (w), days per week (d/w), and minutes (min) of Occupational Therapy (OT) and VR-based therapy per day. N: sample size in the experimental group. TSO: time since stroke (days). NSG: protocol based on non-specific gaming system (i.e., Nintendo Wii). IOT: protocol including intensive occupational therapy. AM: protocol including the amplification of movements in VR. Haptics: protocol including delivery of haptic feedback during training. RUE: percentage of patients with right upper-extremity affected. Sex: percentage of males. Oxf. Class: Count of stroke types (lacunar stroke (LACS) / partial anterior circulation stroke (PACS) / total anterior circulation stroke (TACS) / or posterior circulation stroke (POCS)) according to the Oxford Stroke Classification scale.
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where X i (t) is a given measure on scale i at time t, and X i (t = 0) refers to the corresponding baseline 131 score. This normalization adjusts for the risk of bias due to selecting participants with variable baseline 132 severity of upper limb hemiparesis (Saposnik and Levin, 2011; Medica et al., 2015 
RESULTS

Impact assessment of individual studies
143
We identified ten studies testing the RGS Spheroids protocol (see Methods, Figure S1 ). from the onset of the stroke to the time of baseline evaluation: acute (< 3 weeks), subacute (3 weeks to 151 6 months), early chronic (6-18 months), and late chronic (> 18 months). We observed significant UE 152 structural gains after treatment, both in acute (median 20.0 ± 7.9 MAD, p < .01, Wilcoxon sign-rank) and 153 subacute patients (median 8.0 ± 5.6 MAD, p < .01), as measured by UE-FM (Figure 1 A, Table 2 ). These Table 2 ). More interestingly, at the chronic and late chronic stage, the RGS showed overall 157 effectiveness in facilitating improvements in UE-FM (ranging from median 2.7 ± 3.8 MAD to median 158 7.0 ± 3.6 MAD , p < .05) and CAHAI (median 1.0 ± 3.8 MAD to median 8.0 ± 5.6 MAD , p < .05).
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However, the application of the RGS to domiciliary protocols (chronic at home) showed no significant 160 effects in UE-FM but induced statistically significant but non-clinically relevant gains in the execution of 161 iADLs (median 1.0 ± 1.6 MAD, p < .01). Surprisingly, a dosage-matched RGS study conducted in the 162 clinic on late chronic patients had an impact on UE-FM (condition 15 in Table 1, as measured by UE-FM and CAHAI.
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In general, acute patients that trained with the RGS showed a greater recovery when compared to the standard treatment (Supporting Information, Figure S2 ) and subacute and chronic patients that followed a dosage-matched RGS-based treatment ( Figure 1 , Table 2 ). The analysis of follow-up measures illustrates 169 that improvements were retained in all groups. Interestingly, the subacute subgroup training with RGS 170 exhibited a significant improvement during the follow-up period (3 months) both in UE-FM (median 171 2.0±5.3 MAD, p < 0.01) and CAHAI (median 3.0±11.7 MAD, p < 0.01) (Supporting Information, Figure   172 S3 A and B). The acute groups, however, showed higher inter-individual variability and non-significant 173 gains from the end of the therapy to the follow-up. Table 1 and follow the same order. Shaded areas indicate the data distribution color coded according to the chronicity of stroke patients participating in each study: acute (green), subacute (orange), and early (blue) to late (purple) chronic stage. * for p-value< 0.05 and ** for p-value< 0.01 Table 2 . Impact on Recovery at T1 and Follow-up by treatment condition.
Change from Baseline to T1
Change from T1 to Follow-Up The IDs per row refer to the numeric identifiers of treatment conditions listed in Table 1 .
This is a preprint, not the final typeset article on the patient's chronicity, with a mean improvement of 5.2 ± 1.0 SD % in acute/subacute, and 2.7 ± 0.6 180 SD % and 1.4 ± 0.3 SD % in early and late chronic patients respectively (Figure 2 A) . We observe no 181 significant differences in recovery rates between Occupational Therapy and RGS groups. The change 182 on the CAHAI scale is in the 1 to 4 % range of normalized recovery per week of training with a mean 183 improvement of 5.2 ± 1.0 SD % in acute/subacute, and 2.7 ± 0.6 SD % and 1.4 ± 0.3 SD % in early and 184 late chronic patients respectively. We found statistically significant differences between acute/subacute 185 and early chronic for all groups, even at follow-up (p< 0.01, Wilcoxon Rank-Sum). However, only in the 186 RGS group the early chronic group showed higher recovery rates than the late chronic group (p< 0.05, Wilcoxon Rank-Sum), revealing a long-lasting gradient of recovery potential that remains visible across the first 18 months post-stroke (Figure 2 B Supplementary Information, Figure 3 ).
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The results presented in this study do require further investigation for a number of reasons. First, the 212 observation of non-significant effects in one of the nine studies may be due to low statistical power and 213 risk of bias, however since this study contributes to the final analysis with only 18 data points, it seems 214 highly unprovable that it may have biased our results. Second, the functional relevance of the detected 215 improvements is marginal at chronic stages. The UE-FM minimal clinically important difference (MCID) 216 has been defined as a constant value across the patient's chronicity spectrum, however, this assumption 
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SUPPLEMENTARY TABLES AND FIGURES
A B Figure S1 . Illustration of the Rehabilitation Gaming System (RGS). A: The system consists of a PC, a 17 inch LCD display, a vision-based motion capture device (Kinect 360, Microsoft, Seatle USA) positioned on top of the screen. The virtual tasks logic and graphics were implemented using the Unity 3D (Unity Technologies, San Francisco, USA) and Torque (Garage Games, Las Vegas, NV, USA) computer game engines. The vision-based motion tracking device and data gloves capture the joint movements of the user's torso, shoulders, elbows, and fingers, and map them onto an avatar through a biomechanical model, thus mimicking the movements of the user. Arm and finger movements are displayed on a screen in a first-person perspective, realizing a paradigm that combines goal-oriented action execution, motor imagery, and action observation. B: the Spheroids task follows a proximal to distal training progression where the users are asked to intercept spheres that move towards them (left). Followed by grasping (middle), and placing the spheroids in color matched fashion (right). The scenario is adapted to the performance of the user by controlling the difficulty of the task as defined by the frequency, the speed and the horizontal range of the spheres. Table 2 . Shaded areas indicate the data distribution color coded according to the chronicity of stroke patients participating in each study: acute (green), subacute (orange), and early chronic stage (blue).
